(MedPage Today) — A “top-down” approach of early aggressive therapy for Crohn’s disease continued to achieve better outcomes versus a conventional accelerated “step-up” approach, long-term follow-up data from the PROFILE trial showed.
At 5-year…
Source:
www.medpagetoday.com
Medical Disclaimer:
This content is shared for informational and educational purposes only.
It does not constitute medical, legal, or policy advice.
Healthcare decisions should always be made in consultation with qualified professionals.
